A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells
Gabriela Chiosis(Memorial Sloan Kettering Cancer Center), Neal Rosen(Memorial Sloan Kettering Cancer Center), Brian S. Lucas(Memorial Sloan Kettering Cancer Center), Fuzhong F. Zheng(Memorial Sloan Kettering Cancer Center), Pamela N. Münster(University of California, San Francisco), Laura Sepp‐Lorenzino(Intellia Therapeutics (United States)), Merna N. Timaul(Memorial Sloan Kettering Cancer Center)
Cited by 284
Related Papers
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
|Cancer Research|2006|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
|New England Journal of Medicine|2021|1.7k
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
|Nature|2011|1.4k
BRAF mutation predicts sensitivity to MEK inhibition
|Nature|2005|1.3k